HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Board Certifications: Hematology, Internal Medicine and Medical Oncology
Languages: English
Locations: Hackensack, NJ and North Bergen, NJ
Call Hackensack, NJ: (551) 996-5900
Call North Bergen, NJ: (201) 464-0008
Dr. Martin Gutierrez specializes in medical oncology, thoracic and gastrointestinal oncology. He treats patients in the New Jersey community and is the director of the Drug Discovery/Phase I Unit. He also is a reviewer for the scientific journals Clinical Cancer Research, The Cancer Journal and Cancer Chemotherapy and Pharmacology.
Professional Memberships
American College of Physicians
Massachusetts Medical Society
American Society of Clinical Oncology
American Association for Cancer Research
American Society of Hematology
National Surgical Adjuvant Breast and Bowel Project
Cancer and Leukemia Group B
Radiation Therapy Oncology Group
Cancer Trials Support Unit
Medical Education
Javeriana University School of Medicine
Residency
Javeriana University School of Medicine, residency in internal medicine, Boston Medical Center, residency in internal medicine
Fellowship
National Institutes of Health, fellowship training in medical oncology and hematology
Call Hackensack, NJ: (551) 996-5900
Call North Bergen, NJ: (201) 464-0008
Patients may schedule appointments with Dr. Gutierrez at:
Hackensack University Medical Center
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.